# Shaojing Ma

> Shaojing Ma is a Series A investor at China Venture Capital backing Health Care and Therapeutics. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [China Venture Capital](https://shizune.co/investors/profile/china-venture-capital)
- Total investments: 2
- Last investment: May 2019
- Lead investor: 0%
- Last updated: Aug 2026

Shaojing Ma is a Series A investor at China Venture Capital focused on Health Care and Therapeutics. Shaojing Ma

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Clinical Trials | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alphamab Oncology | Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $60M | Series B | May 28, 2019 |  |
| Alphamab Oncology | Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $100M | Series A | Nov 16, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [Advantech Capital](https://shizune.co/investors/profile/advantech-capital) — VC Fund, 2 deals together
- [PAG](https://shizune.co/investors/profile/pag) — VC Fund, 2 deals together
- [Heritage Provider Network](https://shizune.co/investors/profile/heritage-provider-network) — VC Fund, 1 deal together
- [Janchor Partners](https://shizune.co/investors/profile/janchor-partners) — VC Fund, 1 deal together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 1 deal together

## About China Venture Capital

VC Fund · Beijing, China

China Venture Capital is a venture capital industry trade group.

3 contacts available at China Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Chunsheng Huang | Senior Vice President | https://shizune.co/investors/profile/chunsheng-huang |
| Gu Bo | Chief Investment Officer | https://shizune.co/investors/profile/gu-bo |
| Shaojing Ma | Managing Director | https://shizune.co/investors/profile/shaojing-ma |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Shaojing Ma invest in?

Shaojing Ma invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shaojing Ma last invest?

The most recent investment recorded for Shaojing Ma closed in May 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co